Joan Chang

tranejoan.bsky.social

27 September 2026 13:25

Our lab's #1st manuscript from our #1st #PhD Katie is on #bioRxiv! Check it out 👇🏻 #macrophage regulation of fibroblast #collagen #circadian rhythm. #ImmunoECMatrix w/ @profandrewmac.bsky.social @tracyh9494.bsky.social @mcrcellmatrix.bsky.social @mcf-uom.bsky.social www.biorxiv.org/content/10.1...

Juanma García-Arcos

juanmagararc.bsky.social

11 September 2026 11:10

3/3 Huge thanks to my co-organizers Markku Hakala @mhakala.bsky.social James Conway @jrwconway.bsky.social and Shiqi Wang, and to our sponsors @helsinki.fi, @picoquant.bsky.social, @zeiss-microscopy.bsky.social, @spirochrome.com and @ibidicells.bsky.social for making it possible! #FLIM #FCS

Juanma García-Arcos

juanmagararc.bsky.social

29 August 2026 06:17

Then @jrwconway.bsky.social covered free software for FLIM analysis, FLIM fit , and practical ways to collect an IRF, or prompt. His examples included autofluorescent slides, metal tape, urea crystals, gold nanoparticles and short-lifetime dyes.

Michal Dibus

midibu.bsky.social

10 July 2026 11:13

1/5 🎉 Finally, the results of my main postdoctoral project are out in @natcomms.nature.com! Adhesion-derived condensates control component availability to regulate adhesion dynamics bit.ly/4y9E8Xr Also excited to see the paper highlighted in Nat Comms Editors’ Highlights 🥳 bit.ly/44n4O9i

Garvan Institute

garvaninstitute.bsky.social

09 July 2026 19:34

Dr David Herrmann is leading research to test a new dual-action treatment for triple-negative breast cancer to stop metastasis and shield patients from severe muscle loss, with support from the National Breast Cancer Foundation. 🔗Read more: https://ow.ly/APjU50ZlSWb